Sairekha Suresh

Evidence based Advisory in the time of #COVID-19 (𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠, 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐢𝐬 & 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐨𝐟 𝐌𝐮𝐜𝐨𝐫𝐦𝐲𝐜𝐨𝐬𝐢𝐬) @MoHFW_INDIA @PIB_India @COVIDNewsByMIB @MIB_India #COVID19India #IndiaFightsCOVID19 #mucormycosis #COVID19Update

टाइप 1 डायबिटीज के पेशेंट को साइंटिफिक एविडेंस के साथ किया नॉन-डायबिटिक विधि और अंकित ने नियमित योग करके साथ ही मधुनाशिनी और मधुग्रिट जैसी आयुर्वेदिक दवाओं के सेवन से 800 तक के टाइप 1 डायबिटीज को क्योर कर लिया है और इन्सुलिन भी बंद कर दिया है। #Patanjalis_EvidenceBased_Medicine

@omlakhani Sure, let the IMA officials also respond, you could join the debate.. meanwhile go thru the press release, that might release some of your pressure.

Presenting our first workshop on #CGM in the cloud or what most know as #Nightscout More information and link to register on t1dfindia.org/events #type1diabetes #t1dfi #wearenotwaiting

#blind #t1d Customer and received damagedFiaspInsulin. requestedFor Return and myReturnGotRejected by @pharmeasyapp by Saying packOfThe PenFill is opened. I’m being blind, howWillIKnow myPenFill is broken withoutOpeningThePack? RequestingForReplacement. KindlyRetweet #Justice

#Type1Diabetes is an autoimmune condition often seen in children and young adults. People with #T1D are more prone to getting COVID, like other people with comorbidities. Request to prioritise ppl living with T1D aged 18-45 for #VaccinationDrive @WHO @MoHFW_INDIA #VaccineForT1Ds

#Type1Diabetes is an autoimmune condition often seen in children and young adults. People with #T1D are more prone to getting COVID, like other people with comorbidities. Request to prioritise ppl living with T1D aged 18-45 for #VaccinationDrive @WHO @MoHFW_INDIA #VaccineForT1Ds